<?xml version="1.0" encoding="UTF-8"?>
<p>Other well recognized factors accounting for this elevated risk include a low hemoglobin, low BMI, and increasing age [
 <xref rid="pone.0192030.ref016" ref-type="bibr">16</xref>, 
 <xref rid="pone.0192030.ref019" ref-type="bibr">19</xref>â€“
 <xref rid="pone.0192030.ref022" ref-type="bibr">22</xref>]. Low BMI is a strong independent predictor of mortality among HIV infected individuals even in the context of ART initiation [
 <xref rid="pone.0192030.ref023" ref-type="bibr">23</xref>], with higher BMI levels associated with a protective effect on both mortality and incident TB estimates [
 <xref rid="pone.0192030.ref023" ref-type="bibr">23</xref>, 
 <xref rid="pone.0192030.ref024" ref-type="bibr">24</xref>]. HIV-infected individuals are therefore likely to benefit from micronutrient supplementation, although there have been conflicting reports of their effect on HIV-related co-morbidities or mortality [
 <xref rid="pone.0192030.ref025" ref-type="bibr">25</xref>]. Similarly, determinants for TB among HIV-infected patients vary across settings [
 <xref rid="pone.0192030.ref026" ref-type="bibr">26</xref>].
</p>
